Abstract
The roles of HSP60 and HIF2α in diagnosis, prognosis, and prevention and treatment of various human cancers have been detected. However, the combined roles of HSP60 and HIF2α on the prognosis of patients with gastric cancer remain unclear. In this work, we confirmed that the levels of HSP60 and HIF2α messenger RNA (mRNA) and protein were higher in gastric cancer tissues than that in matched normal tissues by using real-time PCR and Western blot. Furthermore, we confirmed that inhibition of HSP60 or HIF2α could induce apoptosis and inhibit cell mobility. Co-immunoprecipitation (co-IP) was performed to determine the interaction between HSP60 and HIF2α. Lastly, we confirmed that knockdown of HSP60 or HIF2α induced apoptosis in gastric cancer cells is negatively related to the MEK/ERK signaling in vitro. In summary, HSP60 or HIF2α protein expression may be a predictive marker for the prognosis of the patients with gastric cancer. Targeting HSP60 and HIF2α could be a future strategy to improve survival of gastric patients with poor prognosis.
References
May 14, 1999·Trends in Biochemical Sciences·B J Soltys, R S Gupta
Nov 2, 1999·FEBS Letters·E MinetC Michiels
Dec 2, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A FariedH Kuwano
Oct 4, 2005·The Lancet Oncology·Francesco CappelloGiovanni Zummo
Jan 20, 2007·Cancer Science·Ashraf A Khalil, Peter James
Jan 10, 2009·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Axel GlaessgenLars Egevad
Jun 29, 2010·Gynecologic Oncology·Marie CohenPatrick Petignat
Feb 26, 2011·Journal of Gastroenterology·Shinji Tanaka, Shigeki Arii
Jun 15, 2011·Journal of Surgical Oncology·Xin XuJianxing He
Jul 6, 2011·Breast Cancer Research and Treatment·Michelle D HolmesRulla M Tamimi
Oct 7, 2011·The FEBS Journal·Céline HamelinGeneviève Choquet-Kastylevsky
May 9, 2012·Cellular Signalling·Xiao-Rui HanXi-Zhuang Bai
Feb 23, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Elisabet HjerpeElisabeth Avall-Lundqvist
Jul 31, 2013·Molecular and Cellular Biology·Johnny A SenaCheng-Jun Hu
Nov 1, 2013·International Journal of Oncology·Da-Zhi FuYong-Feng Liu
Jan 28, 2014·PloS One·Zhaohu LinXiongwen Zhang
Feb 19, 2014·Genetics and Molecular Research : GMR·H X WangN Li
May 21, 2014·International Journal of Oncology·Shuaiyin ChenQingtang Fan
Sep 11, 2014·PloS One·Xiao-shan LiWei-sheng Luo
Sep 27, 2014·Current Cancer Drug Targets·Evgeniya V Kaigorodova, Mariya V Bogatyuk
Oct 24, 2014·International Journal of Oncology·Wei-Wei TongYin-Zhao Wang
Citations
Oct 4, 2019·The Journal of Pathology·Alberto Jl Macario, Everly Conway de Macario
Dec 22, 2019·Cells·Ya-Hui Huang, Chau-Ting Yeh
Jan 31, 2019·Scientific Reports·Zhenyu XuJing Shen
May 31, 2018·Nature Reviews. Gastroenterology & Hepatology·Eva RathDirk Haller
Apr 24, 2020·Cancer Cell International·Lixian DingGuodong Li
Dec 29, 2018·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Deqing LuoHongyue Ren
May 27, 2020·Trends in Cancer·Jordan O'MalleyDhyan Chandra